These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 566468

  • 1. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney WE.
    Science; 1978 Jul 14; 201(4351):171-3. PubMed ID: 566468
    [Abstract] [Full Text] [Related]

  • 2. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 3. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ, Jakubovic A, Fibiger HC.
    Psychopharmacology (Berl); 1984 Jan 28; 82(4):371-7. PubMed ID: 6427831
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):391-400. PubMed ID: 6322914
    [Abstract] [Full Text] [Related]

  • 5. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
    Allen RM, Lane JD, Brauchi JT.
    Eur J Pharmacol; 1980 Jul 25; 65(2-3):313-5. PubMed ID: 7190503
    [Abstract] [Full Text] [Related]

  • 6. Aging and the regulation of striatal dopaminergic mechanisms in mice.
    Randall PK, Severson JA, Finch CE.
    J Pharmacol Exp Ther; 1981 Dec 25; 219(3):695-700. PubMed ID: 7197719
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF, Thal L, Gardner EL.
    Psychopharmacology (Berl); 1982 Dec 25; 76(2):182-7. PubMed ID: 6805029
    [Abstract] [Full Text] [Related]

  • 8. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM, Kilpatrick G, Hall MD, Jenner P, Marsden CD.
    Psychopharmacology (Berl); 1984 Dec 25; 84(4):512-9. PubMed ID: 6441952
    [Abstract] [Full Text] [Related]

  • 9. Chronic haloperidol treatment potentiates apomorphine- and ethanol-induced hypothermia in the rat.
    Lai H, Kazi MS, Carino MA, Horita A.
    Life Sci; 1982 Mar 08; 30(10):821-6. PubMed ID: 7200179
    [Abstract] [Full Text] [Related]

  • 10. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E, Friedman E.
    Eur J Pharmacol; 1981 Nov 19; 76(1):25-9. PubMed ID: 7318921
    [Abstract] [Full Text] [Related]

  • 11. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
    Carvey PM, Hitri A, Goetz CG, Tanner CM, Klawans HL.
    Life Sci; 1988 Nov 19; 42(22):2207-15. PubMed ID: 3374255
    [Abstract] [Full Text] [Related]

  • 12. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C, Ghi P, Blengio M, Gaietta G, Barrera G, Genazzani E.
    Eur J Pharmacol; 1989 Jul 18; 166(2):149-56. PubMed ID: 2551698
    [Abstract] [Full Text] [Related]

  • 13. Chronic molindone treatment: relative inability to elicit dopamine receptor supersensitivity in rats.
    Meller E.
    Psychopharmacology (Berl); 1982 Jul 18; 76(3):222-7. PubMed ID: 6808540
    [Abstract] [Full Text] [Related]

  • 14. Striatal dopamine receptor supersensitivity after long-term haloperidol treatment of hypophysectomized rats.
    DeLucia R, Scavone C, Camillo MA.
    Braz J Med Biol Res; 1989 Jul 18; 22(6):741-3. PubMed ID: 2620186
    [Abstract] [Full Text] [Related]

  • 15. Differential alteration in striatal dopaminergic and cortical serotonergic receptors induced by repeated administration of haloperidol or centbutindole in rats.
    Gulati A, Srimal RC, Dhawan BN.
    Pharmacology; 1988 Jul 18; 36(6):396-404. PubMed ID: 2901759
    [Abstract] [Full Text] [Related]

  • 16. A dietary haloperidol regimen for inducing dopamine receptor supersensitivity in rats.
    Frey JM, Morgan WW, Ticku MK, Huffman RD.
    Pharmacol Biochem Behav; 1987 Apr 18; 26(4):661-9. PubMed ID: 3602028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.